Stress-induced hyperthermia is reduced by rapid-acting anxiolytic drugs independent of injection stress in rats

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 4, 2009, Pages 413-418

  Vinkers, Christiaan H ^a,b   de Jong, Noëlle M ^a,b   Kalkman, Cor J ^c   Westphal, Koen G C ^a,b   van Oorschot, Ruud ^a,b   Olivier, Berend ^a,b,d   Korte, S Mechiel ^a,b   Groenink, Lucianne ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

8 OH DPAT; Anxiety model; Body temperature; Handling stress; Locomotor activity; Midazolam; Nicotine

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANXIOLYTIC AGENT; MIDAZOLAM;

ANIMAL EXPERIMENT; ANTICIPATORY ANXIETY; ARTICLE; BODY TEMPERATURE MEASUREMENT; CAGE; CANNULA; CONTROLLED STUDY; DRUG EFFECT; DRUG HALF LIFE; INJECTION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS INDUCED HYPERTHERMIA; TELEMETRY;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTI-ANXIETY AGENTS; BODY TEMPERATURE; DRUG INTERACTIONS; FEVER; INJECTIONS, INTRAVENOUS; MALE; MIDAZOLAM; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; SEROTONIN 5-HT1 RECEPTOR AGONISTS; STRESS, PSYCHOLOGICAL; TELEMETRY;

RATTUS;

EID: 67849116718     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.05.017     Document Type: Article

References (26)

1. Borsini F., Lecci A., Volterra G., and Meli A. A model to measure anticipatory anxiety in mice?. Psychopharmacology (Berl) 98 (1989) 207-211
2. Bouwknecht J.A., Olivier B., and Paylor R.E. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse. Neurosci Biobehav Rev 31 (2007) 41-59
3. Chen N.H., and Reith M.E. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem 64 (1995) 1585-1597
4. D'Amico E.J., Neilands T.B., and Zambarano R. Power analysis for multivariate and repeated measures designs: a flexible approach using the SPSS MANOVA procedure. Behav Res Methods Instrum Comput 33 (2001) 479-484
5. de Jong J.G., Wasilewski M., van der Vegt B.J., Buwalda B., and Koolhaas J.M. A single social defeat induces short-lasting behavioral sensitization to amphetamine. Physiol Behav 83 (2005) 805-811
6. Gordon C., Rowsey P., and Yang Y. Effect of repeated nicotine exposure on core temperature and motor activity in male and female rats. J Therm Biol 27 (2002) 485-492
7. 1A receptors. Behav Brain Res 148 (2004) 199-208
8. Lau C.E., Ma F., Wang Y., and Smith C. Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics. Psychopharmacology (Berl) 126 (1996) 241-248
9. Lissek S., Powers A.S., McClure E.B., Phelps E.A., Woldehawariat G., Grillon C., et al. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther 43 (2005) 1391-1424
10. MacNeil G., Sela Y., McIntosh J., and Zacharko R.M. Anxiogenic behavior in the light-dark paradigm follwoing intraventricular administration of cholecystokinin-8S, restraint stress, or uncontrollable footshock in the CD-1 mouse. Pharmacol Biochem Behav 58 (1997) 737-746
11. Mandema J.W., Tukker E., and Danhof M. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration. Br J Pharmacol 102 (1991) 663-668
12. Matta S.G., Balfour D.J., Benowitz N.L., Boyd R.T., Buccafusco J.J., Caggiula A.R., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl) 190 (2007) 269-319
13. A-benzodiazepine receptor complex ligands and stress-induced hyperthermia in singly housed mice. Pharmacol Biochem Behav 72 (2002) 179-188
14. Olivier B., Zethof T., Pattij T., van Boogaert M., van Oorschot R., Leahy C., et al. Stress-induced hyperthermia and anxiety: pharmacological validation. Eur J Pharmacol 463 (2003) 117-132
15. Pattij T., Hijzen T.H., Groenink L., Oosting R.S., van der Gugten J., Maes R.A., et al. Stress-induced hyperthermia in the 5-HT(1A) receptor knockout mouse is normal. Biol Psychiatry 49 (2001) 569-574
16. Petersen D.R., Norris K.J., and Thompson J.A. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab Dispos 12 (1984) 725-731
17. Picciotto M.R., Brunzell D.H., and Caldarone B.J. Effect of nicotine and nicotinic receptors on anxiety and depression. Neuroreport 13 (2002) 1097-1106
18. Reves J.G., Fragen R.J., Vinik H.R., and Greenblatt D.J. Midazolam: pharmacology and uses. Anesthesiology 62 (1985) 310-324
19. Rusyniak D.E., Zaretskaia M.V., Zaretsky D.V., and DiMicco J.A. 3,4-Methylenedioxymethamphetamine- and 8-hydroxy-2-di-n-propylamino-tetralin-induced hypothermia: role and location of 5-hydroxytryptamine 1A receptors. J Pharmacol Exp Ther 323 (2007) 477-487
20. 1A receptors in the behavioral responses associated with innate fear. Behav Neurosci 122 (2008) 611-617
21. van Bogaert M.J., Groenink L., Oosting R.S., Westphal K.G., van der Gugten J., and Olivier B. Mouse strain differences in autonomic responses to stress. Genes Brain Behav 5 (2006) 139-149
22. Van der Heyden J.A., Zethof T.J., and Olivier B. Stress-induced hyperthermia in singly housed mice. Physiol Behav 62 (1997) 463-470
23. Vinkers C.H., Klanker M., Groenink L., Korte S.M., Cook J.M., Van Linn M.L., et al. Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress. Psychopharmacology (Berl) 04 (2009) 299-311
24. Vinkers C.H., van Bogaert M.J., Klanker M., Korte S.M., Oosting R., Hanania T., et al. Translational aspects of pharmacological research into anxiety disorders: the stress-induced hyperthermia (SIH) paradigm. Eur J Pharmacol 585 (2008) 407-425
25. Yu H., and Lewander T. Pharmacokinetic and pharmacodynamic studies of (R)-8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Eur Neuropsychopharmacol 7 (1997) 165-172
26. Zangrossi Jr. H., and File S.E. Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res Bull 29 (1992) 381-388